Yanjia Deng1, Lin Shi2,3, Defeng Wang1,4,5, and ADNI Alzheimer’s Disease Neuroimaging Initiative6
1Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 2Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 3Chow Yuk Ho Technology Centre for Innovative Medicine, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 4Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China, People's Republic of, 5Research Center for Medical Image Computing, Department of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China, People's Republic of, 6Los Angeles, CA, United States
Synopsis
In
order to extend the knowledge on the impaired pattern of “where” visual
perception in mild cognitive impairment (MCI) patients, we investigated the
connectivity of the “where” visual networks in terms of intrinsic interaction in
early and late MCI patients. Resting-state functional MRI data of late MCI,
early MCI and matched healthy controls from Alzheimer’s Disease Neuroimaging
Initiative dataset were analyzed to investigate the alterations of
interregional connections of “where” visual networks. Significant increased
interregional connectivties in late MCI patients were found, which may extend
the current knowledge on the pattern of visual perceptual impairment in MCI
patients.Purpose
Altered regional activation of cortices related to “where”
vision, including the motion and spatial visual perception, previously has been
identified in Alzheimer’s disease (AD)/mild cognitive impairment (MCI)
patients. More importantly, several studies have demonstrated
1, 2 that the decline of
“where” visual function may contribute to the intellectual deterioration in AD.
Thus, better understanding of “where” visual dysfunction would be helpful for
diagnosis of AD and interpretation of cognitive evaluations
3. Therefore, in this
study, in order to extend the knowledge on the impaired pattern of “where”
visual perception in MCI patients, we aim to further investigate the connectivity
of the “where” visual networks in terms of intrinsic interaction in early and
late MCI patients.
Methods
To achieve the above aim, the study was carried out in
two steps. First step, the activation likelihood estimation (ALE) analysis, a
coordinate-base meta-analysis approach, was performed to locate the cortices of
“where” visions. The coordinates of “where” visual cortices were obtained from
the results of ALE analysis, and then were applied in second step to define the
cortical regions of interest (ROIs) of HLV cortices. In the second step, the
resting-state functional MRI (rs-fMRI) data of 131 subjects (including 52 early
MCI (EMCI), 35 late MCI (LMCI) and 44 normal control (CN)) from the Alzheimer’s
Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu) were
analyzed to investigate the alternations of “where” visual network. The
resting-state functional connectivity (RSFC) between each pair of ROIs
calculated as the correlation between the rs-fMRI time courses of the two ROIs
was compared among the three groups.
Results
Cortices and ROIs of “where” vision
Totally, 22 significant clusters were found, which were
mainly located in the bilateral occipital complex, superior parietal lobule,
postcentral gyrus, inferior frontal gyrus and fusiform gyrus (Figure1). Based
on the coordinates and BA regions of these clusters, 25 spherical ROIs were
defined for “where” visual networks.
Interregional RSFC
changes
Significant altered connectivities among the three
groups included right postcentral gyrus-right fusiform, left postcentral
gyrus-right fusiform and right fusiform-right thalamus. The Post Hoc analysis
demonstrated that all these altered connectivities were significantly increased
in LMCI group (Figure2).
Discussion
In the present study, based on the RSFC and the
probabilistic mapping of “where” visual cortices, abnormal RSFC was identified
among several connections of “where” visual network at the late MCI stage. The
involved brain regions included the bilateral poscentral gyrus, fusiform gyrus
and thalamus. The postcentral gyrus is consistently active during action
perception and execution, and may thus be considered as a brain region for
motion perception
4. Besides, its
increased activation in MCI was consistently found in Agosta F’s study
5, thus may
corroborate our findings. Finally, in line with previous studies
6, increased
correlation between thalamus and fusiform gyrus was found in AD patients, and correlated with cognitive decline. We
speculated that the elevated RSFCs in late MCI patients may imply the
disruption of “where” visual network in MCI patients.
Conclusion
In
this study, we investigated the “where” visual network changes in early and
late MCI patients from the aspect of interregional connectivity. The findings indicated
that the alternation of the “where” visual networks developed in late MCI
stage, and confirmed our hypothesis. These findings could extend the current
knowledge on the pattern of visual
perceptual impairment in MCI patients, and could be helpful for understanding
the neuroanatomical basis of their clinical dysfunctions.
Acknowledgements
The work described in this
paper was supported by a grant from the Research Grants Council of the Hong
Kong Special Administrative Region, China (Project No.: CUHK 14113214), a grant
from The Science, Technology and Innovation Commission of Shenzhen Municipality (Project
No. CXZZ20140606164105361), and the direct grant at CUHK (Project No.: 4054229).
Data
collection and sharing for this project was funded by the Alzheimer's Disease
Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01
AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012).
ADNI is funded by the National Institute on Aging, the National Institute of
Biomedical Imaging and Bioengineering, and through generous contributions from
the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery
Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb
Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and
Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company
Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer
Immunotherapy Research & Development, LLC.; Johnson & Johnson
Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck &
Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack
Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal
Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics.
The Canadian Institutes of Health Research is providing funds to support ADNI
clinical sites in Canada. Private sector contributions are facilitated by the
Foundation for the National Institutes of Health (www.fnih.org). The grantee
organization is the Northern California Institute for Research and Education,
and the study is coordinated by the Alzheimer's Disease Cooperative Study at
the University of California, San Diego. ADNI data are disseminated by the
Laboratory for Neuro Imaging at the University of Southern California.
References
1 Rizzo M, Anderson SW, Dawson J,
et al, Vision and cognition in Alzheimer's disease. Neuropsychologia 2000;38(8):1157-1169.
2 Silveri MC, Leggio MG,
Influence of disorders of visual perception in word-to-picture matching tasks
in patients with Alzheimer's disease. Brain Lang. 1996;54(2):326-334.
3 Cronin-Golomb Corkin A, Growdon
JH, Visual dysfunction predicts cognitive deficits in Alzheimer's disease.
Optom Vis Sci. 1995;72(3):168-176.
4 Kalenine S, Buxbaum LJ, Coslett
HB, Critical brain regions for action recognition: lesion symptom mapping in
left hemisphere stroke. Brain 2010;133 (11) 3269-3280.
5 Agosta F, Rocca MA, Pagani E, et
al, Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's
disease. Hum
Brain Mapp. 2010;31(4):515-525.
6 Zhou B, Liu Y, Zhang Z, et al. Impaired functional connectivity of the
thalamus in Alzheimer's disease and mild cognitive impairment: a resting-state
fMRI study. Curr Alzheimer Res. 2013;10 (7):754-766.